<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nonrandom chromosome changes have been identified in a number of malignant human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0001909'>leukemias</z:hpo> are among the best studied malignant cells and they provide the largest body of relevant cytogenetic data </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo>, a reasonably consistent translocation [t(9;22) (q34;q11)] is observed in 93 percent of <z:hpo ids='HP_0000001'>all</z:hpo> Ph1 positive patients </plain></SENT>
<SENT sid="3" pm="."><plain>In the other patients, translocations are either two-way, involving No. 22 with some other chromosome or complex translocations involving Nos </plain></SENT>
<SENT sid="4" pm="."><plain>9 and 22 and another chromosome </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, two translocations are each specifically associated with leukemic cells arrested at two different stages of maturation </plain></SENT>
<SENT sid="6" pm="."><plain>One of these, t(8;21)(q22;q22), is found mainly in patients with <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> with maturation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M2) </plain></SENT>
<SENT sid="7" pm="."><plain>The other, t(15;17)(q22?;q21?), is seen only in patients with <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> (APL-M3) </plain></SENT>
<SENT sid="8" pm="."><plain>Various translocations have been observed in B-cell <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> or in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The most common is t(8;14)(q24;q32), but variants of this, namely t(2;8)(p13?;q24) and t(8;22)(q24;q11), have also been observed; in <z:hpo ids='HP_0000001'>all</z:hpo> of these, the consistent change involves 8q24 </plain></SENT>
<SENT sid="10" pm="."><plain>The various immunoglobulin loci are located on chromosomes 2, 14, and 22 in the same chromosome band affected by the translocations in B-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>These translocations may occur randomly </plain></SENT>
<SENT sid="12" pm="."><plain>If a specific translocation provides a particular cell type with a growth advantage, then selection could act to cause the proliferation of this aneuploid cell line vis-a-vis cells with a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype </plain></SENT>
<SENT sid="13" pm="."><plain>In this view, the chromosome change could be the fundamental event leading to the leukemic transformation of an otherwise <z:mpath ids='MPATH_458'>normal</z:mpath> cell </plain></SENT>
<SENT sid="14" pm="."><plain>The challenge for the future is to define the genes located at the sites of consistent translocations in myeloid <z:hpo ids='HP_0001909'>leukemias</z:hpo> and to determine the alterations in gene function that are associated with the translocation </plain></SENT>
</text></document>